🇪🇸 Spain · EU Public Tender
Suministro de fármacos con exclusividad para el Instituto Catalán de Oncología; -LOTE 10 del fármaco exclusivo ABEMACICLIB 50mg, ABEMACICLIB 100mg, ABEMACICLIB 150 mg comprimidos
🏛️ Instituto Catalán de Oncologia · 📍 Hospitalet de Llobregat
—
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Awarded to | Lilly, S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.